Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: Systematic review and meta-analysis

British Journal of Anaesthesia

Volumn 112, Issue 1, 2014, Pages 25-34

  Gillies, M A ^a   Habicher, M ^b   Jhanji, S ^c   Sander, M ^b   Mythen, M ^d   Hamilton, M ^e   Pearse, R M ^f  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^e ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

hetastarch; meta analysis; surgery

Indexed keywords

HETASTARCH;

ACUTE KIDNEY FAILURE; CRITICALLY ILL PATIENT; CRYSTALLOID; DRUG FATALITY; HEART SURGERY; HUMAN; INCIDENCE; KIDNEY FUNCTION; META ANALYSIS; MORTALITY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMATIC REVIEW; VASCULAR SURGERY;

EID: 84882759031     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet303     Document Type: Article

References (54)

1. Pearse RM, Moreno RP, Bauer P, et al. Mortality after surgery in Europe: aday cohort study. Lancet 2012; 380: 1059-65
2. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372: 139-44
3. Pearse RM, Ackland GL. Perioperative fluid therapy. Br Med J 2012; 344: e2865
4. Finfer SF, Liu BF, Taylor CF, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 2010; 14: R185
5. Ertmer C, Kampmeier T,Van Aken H. Fluid therapyin critical illness:a special focus on indication, the use of hydroxyethyl starch and its different raw materials. Curr Opin Anaesthesiol 2013; 26: 253-60
6. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-11
7. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-34
8. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-39
9. Hecht-Dolnik M, Barkan H, Taharka A, Loftus J. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 2009; 138: 703-11
10. Prowle JR, Pearse RM. Is it the end of the road for synthetic starches in critical illness? Br Med J 2013; 346: 1805
11. SchortgenFF,BrochardL.Withdrawing synthetic colloids in sepsis is possible and safe. Crit Care Med 2012; 40: 2709-10
12. Reilly C. Retraction. Notice of formal retraction of articles by Dr. Joachim Boldt. Br J Anaesth 2011; 107: 116-7
13. Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010; 20: CD007594
14. Gattas DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013; 39: 558-68
15. Patel A, Waheed U, Brett SJ. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 2013; 39: 811-22
16. Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118: 387-94
17. Van Der Linden P, James M, Mythen M, et al. Safety of modern starches used during surgery. Anesth Analg 2013; 116: 35-48
18. MoherD, LiberatiA, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097
19. Olivo SA, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ. Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther 2008; 88: 156-75
20. Alavi SM, Ahmadi BB, Baharestani B, Babaei T. Comparison of the effects of gelatin, ringer's solution and a modern hydroxyl ethyl starch solution after coronary artery bypass graft surgery. Cardiovasc J Afr 2012; 23: 428-31
21. Dehne MG, Muhling J, Sablotzki A, Dehne K, Sucke N, Hempelmann G. Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment. J Clin Anesth 2001; 13: 103-11
22. Diehl JT, Lester JL III, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg 1982; 34: 674-9
23. Feldheiser A, Pavlova V, Bonomo T, et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth 2013; 110: 231-40
24. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 2008; 25: 986-94
25. Gondos T, Marjanek Z, Ulakcsai Z, et al. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesthesiol 2010; 27: 794-800
26. Guo X, Xu Z, Ren H, Luo A, Huang Y, Ye T. Effect of volume replacement with hydroxyethyl starch solution on splanchnic oxygenation in patients undergoing cytoreductive surgery for ovarian cancer. Chin Med J 2003; 116: 996-1000
27. Hung M, Zou C, Lin F, Lin C, Chan K, Chen Y. New 6% hydroxyethyl starch 130/0.4 does not increase blood loss during major abdominal surgery. A randomized, controlled trial. J Formos Med Assoc, 2012, doi:10.1016/j.jfma.2012. 08.002
28. Kuitunen AH, Hynynen MJ,Vahtera E, SalmenperaMT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 2004; 98: 291-7
29. Lee JS, Ahn SW, Song JW, Shim JK, Yoo KJ, Kwak YL. Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery. Circ J 2011; 75: 2397-402
30. Mahmood A, Gosling P, Barclay R, Kilvington F, Vohra R. Splanchnic microcirculation protection by hydroxyethyl starches during abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 2009; 37: 319-25
31. Marik PE, Iglesias J, Maini B. Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Crit Care 1997; 12: 51-5
32. Munsch CM, MacIntyre E, Machin SJ, Mackie IJ, Treasure T. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg 1988; 75: 675-8
33. Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Ann 2009; 17: 368-72
34. Sirvinskas E, Sneider E, Svagzdiene M, et al. Hypertonic hydroxyethyl starch solution for hypovolaemia correction following heart surgery. Perfusion 2007; 22: 121-7
35. Van der Linden PJ, De Hert SG, Daper A, et al. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth 2004; 51: 236-41
36. Van der Linden PJ, De Hert SG, Deraedt D, et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005; 101: 629-34
37. Verheij J, Lingen A, Beishuizen A, et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 2006; 32: 1030-8
38. Ando Y, Terao Y, Fukusaki M, et al. Influence of low-molecularweight hydroxyethyl starch on microvascular permeability in patients undergoing abdominal surgery: comparison with crystalloid. J Anesth 2008; 22: 391-6
39. Belcher P, Lennox SC. Avoidance of blood transfusion in coronary artery surgery: a trial of hydroxyethyl starch. Ann Thorac Surg 1984; 37: 365-70
40. Harten J, Crozier JE, McCreath B, et al. Effect of intraoperative fluid optimisation on renal function in patients undergoing emergency abdominal surgery: a randomised controlled pilot study. Int J Surg 2008; 6: 197-204
41. Senagore AJ, Emery T, Luchtefeld M, Kim D, Dujovny N, Hoedema R. Fluid management for laparoscopic colectomy: a prospective, randomized assessment of goal-directed administration of balanced salt solution or hetastarch coupled with an enhanced recovery program. Dis Colon Rectum 2009; 52: 1935-40
42. Shahbazi S, Zeighami D, Allahyary E, Alipour A, Esmaeeli MJ, Ghaneie M. Effect of colloid versus crystalloid administration of cardiopulmonary bypass prime solutionontissueandorganperfusion. Iran Cardiovasc Res J 2011; 5: 35-41
43. TiryakiogluO,YildizG,Vural H,GoncuT,OzyaziciogluA,YavuzS.Hydroxyethyl starch versus ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg 2008; 3: 45
44. HonkonenEL, Jarvela K, Huhtala H,HolmP, Lindgren L. Hyperosmolality does not modulate natriuretic peptide concentration in patients after coronary artery surgery. Acta Anaesthesiol Scand 2009; 53: 565-72
45. Kasper SM, Walter M, Grune F, Bischoff A, Erasmi H, Buzello W. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996; 83: 921-7
46. Magder S, Potter BJ, Varennes BD, Doucette S, Fergusson D; Canadian Critical Care Trials Group. Fluids after cardiac surgery: a pilot study of the use of colloids versus crystalloids. Crit Care Med 2010; 38: 2117-24
47. Olofsson CI, Gorecki AZ, Dirksen R, et al. Evaluation of MP4OX for prevention of perioperative hypotension inpatients undergoing primary hip arthroplasty with spinal anesthesia: a randomized, double-blind, multicenter study. Anesthesiology 2011; 114: 1048-63
48. Sirieix D, Hongnat JM, Delayance S, et al. Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. Crit Care Med 1999; 27: 2159-65
49. Standl T, Burmeister MA, Horn EP, Wilhelm S, Knoefel WT, Schulte am Esch J. Bovine haemoglobin-based oxygen carrier for patients undergoing haemodilution before liver resection. Br J Anaesth 1998; 80: 189-94
50. Challand C, Struthers R, Sneyd JR, et al. Randomized controlled trial of intraoperative goal-directed fluid therapy in aerobically fit and unfit patients having major colorectal surgery. Br J Anaesth 2012; 108: 53-62
51. Mukhtar A, Aboulfetouh F, Obayah G, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesth Analg 2009; 109: 924-30
52. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technologyneeds: theSecondInternationalConsensusConference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-212
53. Murray GF, Solanke T, Thompson WL, Ballinger WF. Hydroxyethyl starch as a plasma expander in hemorrhagic shock. Surg Forum 1965; 16: 34-5
54. Van der Linden P, Gazdzik TS, Jahoda D. A double-blind, randomized, multicenter study of MP4OX for treatment of perioperative hypotension in patients undergoing primary hip arthroplasty under spinal anesthesia. Anesth Analg 2011; 112: 759-73